ProPhase Labs, Inc. (PRPH): Price and Financial Metrics
PRPH Price/Volume Stats
| Current price | $4.71 | 52-week high | $9.94 |
| Prev. close | $4.95 | 52-week low | $4.05 |
| Day low | $4.60 | Volume | 59,961 |
| Day high | $4.95 | Avg. volume | 45,756 |
| 50-day MA | $5.50 | Dividend yield | N/A |
| 200-day MA | $5.17 | Market Cap | 84.99M |
PRPH Stock Price Chart Interactive Chart >
ProPhase Labs, Inc. (PRPH) Company Bio
ProPhase Labs, Inc. manufactures zinc gluconate glycine lozenges and homeopathic gum. The Company's products reduce the duration and severity of common cold symptoms. ProPhase also manufactures nutrition and weight management products.
Latest PRPH News From Around the Web
Below are the latest news stories about PROPHASE LABS INC that investors may wish to consider to help them evaluate PRPH as an investment opportunity.
ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call TranscriptProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call Transcript November 9, 2023 ProPhase Labs, Inc. misses on earnings expectations. Reported EPS is $-0.3 EPS, expectations were $-0.2. Operator: Good day and welcome the ProPhase Labs Incorporated Third Quarter 2023 Financial Results and Corporate Update. All participants will be in listen-only mode. [Operator Instructions] After today’s […] |
ProPhase Labs Inc (PRPH) Reports Mixed Q3 Results Amid Strategic TransformationsFinancial and Operational Highlights for the Third Quarter of 2023 |
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023Company sees significant momentum in Pharmaloz, Nebula Genomics and ProPhase BioPharma Pharmaloz Manufacturing plans on track to increase capacity from $10 million to over $75 million in 2024 Indications of demand for entire planned capacity expansion Nebula Genomics opens new, state of the art Whole Genome Sequencing lab in Garden City, NY. Strong indications for demand lead to significant planned capacity expansion. Company to hold a conference call Thursday, November 9, 2023, at 11:00 AM ET G |
ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern TimeGARDEN CITY, NY, Nov. 02, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, will hold a conference call on Thursday, November 9, 2023, at 11:00 a.m. Eastern time to discuss its results for the third quarter ended September 30, 2023 and provide a business update. A press release detailing these results will be issued prior to the call. ProPhase Labs’ CEO and Chairman of the Board of Directors, Ted Karkus, will h |
ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.Pharmaloz plan is to build capacity with a goal to attain a revenue run-rate of $60 to $80 million by year-end 2024, with 20-25% pre-tax net margins and a goal for additional growth thereafter. Garden City, NY, Oct. 17, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, today unveiled the substantial expansion strategy for its wholly-owned subsidiary, Pharmaloz Manufacturing, Inc. (PMI). Pharmaloz is a large loz |
PRPH Price Returns
| 1-mo | -24.76% |
| 3-mo | -4.66% |
| 6-mo | 4.11% |
| 1-year | -37.94% |
| 3-year | -15.74% |
| 5-year | 57.00% |
| YTD | 4.20% |
| 2023 | -53.06% |
| 2022 | 34.31% |
| 2021 | -21.90% |
| 2020 | 365.99% |
| 2019 | -37.46% |
Continue Researching PRPH
Here are a few links from around the web to help you further your research on ProPhase Labs Inc's stock as an investment opportunity:ProPhase Labs Inc (PRPH) Stock Price | Nasdaq
ProPhase Labs Inc (PRPH) Stock Quote, History and News - Yahoo Finance
ProPhase Labs Inc (PRPH) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...